George Scangos (L) and Marianne De Backer

January 25, 2023 08:31 AM ESTUpdated January 26, 08:58 AM

Pioneering biotech icon George Scangos hands in his retirement papers — and this time it’s for real

George Scangos, one of the all-time great biotech CEOs, says the time has come to turn over the reins one last time.

The 74-year-old biotech …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE LOG IN

ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

view job offer post your job now

TRENDING NOW

Trump asks 'very tough hombre' Dr. Oz to lead MFN talks

US warns drugmakers against misrepresenting cost of imported products

Endpoints 100 biotech survey: Welcome to the summer of biotech’s discontent

About 5% of CBER and CDER left after FDA staff cuts, analysis finds

Meet the ‘first sale’ rule: A customs loophole pharma companies could use to ease tariff impact

sponsored

Does your supply chain hold up under pressure for high-risk temperature-critical shipments?